CoChat

Alternative splicing in disease and therapy

Garcia-Blanco, Mariano A, Baraniak, Andrew P, Lasda, Erika L · 2004 · Nature Biotechnology

The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.

Abstract

Alternative splicing is the major source of proteome diversity in humans and thus is highly relevant to disease and therapy. For example, recent work suggests that the long-sought-after target of the analgesic acetaminophen is a neural-specific, alternatively spliced isoform of cyclooxygenase 1 (COX-1). Several important diseases, such as cystic fibrosis, have been linked with mutations or variations in either cis-acting elements or trans-acting factors that lead to aberrant splicing and abnormal protein production. Correction of erroneous splicing is thus an important goal of molecular therapies. Recent experiments have used modified oligonucleotides to inhibit cryptic exons or to activate exons weakened by mutations, suggesting that these reagents could eventually lead to effective therapies.

Overview

Integrity signals

Registry

Crossref · 10.1038/nbt964

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 192 references

Cited by

Items 201–300 of 529

Metadata

Authors
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L.
Affiliations
Duke University (US)
Venue
Nature Biotechnology
Published
2004-05
Volume
22
Issue
5
Pages
535-546
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2070564797
Cited by
527
References
192
Citations by year
2026: 3 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 15 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 21 · 2014: 20 · 2013: 28 · 2012: 33
FWCI
16.58
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R33CA097502, R33 CA97502)
  • National Institute of General Medical Sciences (R01GM063090, R01 GM 63090)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
alternative splicing, proteome diversity, cystic fibrosis, aberrant splicing, cis-regulatory elements, trans-acting splicing factors, cyclooxygenase-1, paracetamol, cryptic exons, modified oligonucleotides, splicing correction, molecular therapy
MeSH terms
Base Sequence, Humans, Phenotype, RNA, Therapeutics, Alternative Splicing, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.